Bharadwaj, S. S., Poojary, B., Nandish, S. K. M., Kengaiah, J., Kirana, M. P., Shankar, M. K., . . . Sannaningaiah, D. (2018). Efficient Synthesis and in Silico Studies of the Benzimidazole Hybrid Scaffold with the Quinolinyloxadiazole Skeleton with Potential α-Glucosidase Inhibitory, Anticoagulant, and Antiplatelet Activities for Type-II Diabetes Mellitus Management and Treating Thrombotic Disorders. ACS Omega.
Citação norma ChicagoBharadwaj, S. Shashidhar, Boja Poojary, Sharath Kumar M. Nandish, Jayanna Kengaiah, Mugaranja P. Kirana, Madan Kumar Shankar, Anupam J. Das, Ananda Kulal, and Devaraja Sannaningaiah. "Efficient Synthesis and in Silico Studies of the Benzimidazole Hybrid Scaffold With the Quinolinyloxadiazole Skeleton With Potential α-Glucosidase Inhibitory, Anticoagulant, and Antiplatelet Activities for Type-II Diabetes Mellitus Management and Treating Thrombotic Disorders." ACS Omega 2018.
MLA citiranjeBharadwaj, S. Shashidhar, et al. "Efficient Synthesis and in Silico Studies of the Benzimidazole Hybrid Scaffold With the Quinolinyloxadiazole Skeleton With Potential α-Glucosidase Inhibitory, Anticoagulant, and Antiplatelet Activities for Type-II Diabetes Mellitus Management and Treating Thrombotic Disorders." ACS Omega 2018.